MoneyWorks4Me

Dr. Reddys Laboratories informs about press release

11 Aug 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 11th August   2020 ‘Dr. Reddy's Laboratories announces the First-to Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.60
Dr. Reddys Labs. 1194.90
Cipla 1332.30
Lupin 2004.30
Zydus Lifesciences 1152.20
View more..